kabutan

Renascience Inc.(4889) Summary

4889
TSE Growth
Renascience Inc.
1,199
JPY
+20
(+1.70%)
Apr 28, 3:30 pm JST
7.53
USD
Apr 28, 2:30 am EDT
Result
PTS
outside of trading hours
1,191
Apr 28, 10:46 pm JST
Summary Chart Historical News Financial Result
PER
PBR
6.85
Yield
ー%
Margin Trading Ratio
Stock Price
Apr 28, 2026
Opening Apr 28, 9:00 am
1,187 JPY 7.44 USD
Previous Close Apr 27
1,179 JPY 7.39 USD
High Apr 28, 2:58 pm
1,209 JPY 7.59 USD
Low Apr 28, 9:13 am
1,111 JPY 6.97 USD
Volume
411,400
Trading Value
0.49B JPY 3.05M USD
VWAP
1180.99 JPY 7.42 USD
Minimum Trading Value
119,900 JPY 753 USD
Market Cap
0.02T JPY 0.10B USD
Number of Trades
1,808
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
High
1-Year Average
3,789
1-Year High May 21, 2025
38,929
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 0 1,347,600
Apr 17, 2026 0 1,472,800
Apr 10, 2026 0 1,481,400
Apr 3, 2026 0 1,464,500
Mar 27, 2026 0 1,417,900
Company Profile
Renascience Inc. is a drug discovery venture originating from Tohoku University. The company focuses on developing therapeutic drugs using small molecule compounds and leverages AI for medical solutions.
Sector
Pharmaceuticals
Renascience Inc., a drug discovery venture born out of Tohoku University, is advancing the development of therapeutic drugs using small molecule compounds, with a focus on PAI-1 inhibitors. The company conducts clinical development in areas related to aging and lifestyle-associated diseases, including cancer, respiratory diseases, and mental disorders, and has a strong track record in physician-led clinical trials. Renascience Inc. is also committed to developing AI-powered medical devices, with pipelines in pulmonary function test diagnostics, maintenance hemodialysis support, and diabetes treatment assistance. The company emphasizes collaborative research with universities and medical institutions, having established an open innovation laboratory. With an integrated research and development system spanning from basic research to clinical development, Renascience Inc. aims to create medical innovations.